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osting by EAbstract Objective: To investigate the inﬂuence of factors such as age, gender and pre-operative
behavior rating on the outcome of sedation using oral trimeprazine during dental treatment of chil-
dren.
Method: Records of children who received dental treatment under sedation with oral trimeprazine
between 2000 and 2007 were reviewed and the following data were obtained: age and weight of
patient at the time of treatment, gender, behavior classiﬁcation prior to sedation, dose of medica-
tion used, efﬁcacy of sedation and treatment accomplished. Descriptive statistics, cross-tabulations
and v2 analysis were done.
Result: Forty-eight sedation sessions met the inclusive criteria for children whose mean age was
4.92 (SD 1.65, range 3.0–8.0) years and mean weight was 18.23 (SD 4.82, range: 12.0–31.0) kg.
Overall, 54.2% (26/48) of the sedations were rated successful, 20.8% (10/48) were partially success-
ful and 25.0% (12/48) not successful. Younger children 3–5 years, and those with only negative pre-
operative behavior rating had more successful sedation sessions than older, 6–8 years or children
with deﬁnitely negative pre-operative behavior rating (X2 = 8.165, p = .017) and (X2 = 17.258,
p= .001), respectively.
Conclusion: Variables such as patient’s age and pre-operative behavior but not gender and type of
treatment could predict outcome of dental sedation using trimeprazine in children.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1 468 2145.
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lsevier1. Introduction
Sedation for dental procedures is used primarily to allay anx-
iety and provide a more relaxed feeling during treatment. In
children, sedation is often administered to control behavior
to allow the safe completion of a procedure (AAPD, 2010).
As a major adjunct for behavioral management in pediatric
dentistry, it facilitates the provision of comprehensive dental
care to patients who would otherwise not receive it and a
reduction in dental fear that would otherwise complicate
88 L.L. Bellofuture care (Nathan and Vargas, 2002). The sedation of chil-
dren for the delivery of oral health care is recognized by pedi-
atric dentists as a unique clinical challenge. The outcome is
variable and depends upon each patient’s response to various
drugs/agents.
Sedative-hypnotics, anxiolytics or narcotic agents have been
used by several investigators to control inappropriate behaviors
in children receiving dental treatment. There is however, no
consensus among pediatric dentists as to which agents or com-
bination of agents or technique is superior in its efﬁcacy for
dental procedural sedation (Matharu and Ashley, 2005). How-
ever, any agent used for sedation in the pediatric patient for
diagnostic and therapeutic procedures should: (a) guard the pa-
tient’s safety and welfare; (b) minimize physical discomfort and
pain; (c) control anxiety; minimize psychological trauma, and
maximize the potential for amnesia; (d) control behavior and/
or movement so as to allow the safe completion of the proce-
dure; and (e) return the patient to a state in which safe discharge
from medical supervision is possible (AAPD, 2010).
Trimeprazine tartrate is a phenothiazine derivative antihis-
tamine which also has sedative-hypnotic properties. It has weak
anti-cholinergic action and slight anti-emetic and anti-musca-
rinic effects (United States Pharmacopea, 1990). It has been
widely used for premedication of children prior to induction
of general anesthesia for more than 50 years (Layﬁeld and
Walker, 1984; Padﬁeld et al., 1986; Phillips et al., 1990; Mitchell
et al., 1997). Dosages such as 2 mg/kg (Padﬁeld et al., 1986;
Mitchell et al., 1997; Patel and Meakin, 1997); 3 mg/kg (Peters
and Brunton, 1982; Thomas et al., 1987) and 4 mg/kg (Van der
Walt et al., 1987), have been used by different investigators and
each had reported varying degrees of success. Adverse effects,
such as central nervous system (CNS) depression, hypotension
and bradycardia resulting from high doses have been reported
(Loan and Cuthbert, 1985). Simonoff and Stores (1987) used
6 mg/kg dose in 1–3 year old children with night waking prob-
lems and they reported satisfactory result without side effects.
Subsequent studies began to examine the efﬁcacy of trimepra-
zine as an agent for sedation in more stressful situations such
as those during pain management in pediatric intensive care
(Thomas et al., 1987; Van der Walt et al., 1987; Ong et al.,
1996), and pediatric dental treatment (Bello and Darwish,
1994; Roelofse et al., 1998; Al Harbi, 2004). When used as
the sole sedative agent for apprehensive and uncooperative
children prior to dental treatment, low dose of Trimeprazine
(<3 mg/kg) which was considered satisfactory for preinduction
was not enough to control behavior to allow safe completion of
dental procedure. A higher dose (3.5–4.0 mg/kg) has been
found to provide satisfactory sedation for most children but
often result in prolonged emergence from the medication (Bello
and Darwish, 1994). Because of variability in patients’ response
and sedation outcome, it is essential to determine factors that
are associated with these characteristics.
The purpose of this retrospective study was to investigate
the inﬂuence of factors such as age, gender and pre-operative
behavior of the patient on the outcome of sedation using tri-
meprazine tartrate for children receiving dental treatment.
2. Methods
Following approval by the Institutional Review Board of the
College of Dentistry Research Center (CDRC), records of chil-dren who received dental treatment using trimeprazine as the
sole sedative agent at the Pediatric Clinic of the College of
Dentistry, King Saud University between 2000 and 2007 were
reviewed. The children were sedated because of behavior man-
agement difﬁculties with conventional care during previous
dental visit. All patients were treated by either a consultant
pediatric dentist or a postgraduate student under direct super-
vision. Patients that were healthy: American Society of Anes-
thesiologist Category 1 (ASA 1) and aged between 3 and
8 years were included. Patients with physical disabilities or
known psychological and medical disorders were excluded.
The sedation protocol followed the guidelines established
by the American Academy of Pediatric Dentistry (AAPD,
2010). Informed consent was obtained from the parent for
sedation appointment, and then medical history was reviewed,
dietary precautions, pre- and post- operative instructions were
given. Physical assessment including airway, patient weight
and vital signs was performed. Pre-operative behavior dis-
played by the child was rated using Frankl behavior rating
scale (Frankl et al., 1962). Behavior was classiﬁed as: deﬁnitely
negative (refusal of treatment, crying forcefully, fearful or any
other overt evidence of extreme behavior) or negative (reluc-
tant to accept treatment, uncooperative, evidence of negative
attitude; sullen withdrawn). Each patient was given oral tri-
meprazine dosage of 3.8 mg/kg. Local anesthesia used was
2% Lidocaine with 1:100,000 epinephrine (maximum dosage
of 4.0 mg/kg). At the end of each session, overall effectiveness
of sedation was recorded as successful, partially successful or
unsuccessful. Successful sedation was deﬁned as no crying or
movement or some limited crying or movements which did
not interrupt treatment. All intended procedures were com-
pleted. Partially successful was deﬁned as moderate crying or
movements which interrupted treatment but eventually all in-
tended treatment was completed. Unsuccessful sedation was
recorded when treatment was discontinued or interrupted
due to uncooperative behavior and only partial treatment
rendered.
The following data were obtained from the records. Age
and weight of patient at the time of treatment, gender, behav-
ior rating prior to sedation, treatment accomplished and seda-
tion outcome.
Data were analyzed using SPSS program version 10.
Descriptive statistics were generated and v2 test used in the sta-
tistical evaluation of frequency distributions. A p-value of
<.05 was selected to denote statistical signiﬁcance.
3. Results
Forty-eight sedation records were selected for analysis from
the available 66 ﬁles. Eighteen sedation records were elimi-
nated from the review because they lacked complete informa-
tion regarding variables selected for analysis.
The mean age (SD) of the children was 4.92 (1.65); range:
3.0–8.0 years; and a mean weight (SD) of 18.23 (4.82); range:
12.0–31.0 kg. There were 21 (43.8%) males and 27 (56.2%) fe-
males (Table 1).
Overall 54.2% (26/48) of the sedation was rated successful,
20.8% (10/48) partially successful and 25.0% (12/48) unsuc-
cessful. In order to determine if there was any association
between sedation outcome and age, the subjects were divided
into two age groups: 3–5 and 6–8 years. v2 analysis showed
Table 4 Comparison of trimeprazine sedation outcome by
gender.
Sedation outcome Gender
Male N (%) Female N (%)
Successful 12 (46.2) 14 (53.8)
Partially successful 5 (50.0) 5 (50.0)
Unsuccessful 4 (33.3) 8 (66.7)
v2 = 0.749, df = 2, p= .688.
Table 1 Descriptive characteristics for the subjects.
Variable Mean SD Range
Age (years) 4.92 1.65 3.0–8.0
Weight (kg) 18.23 4.82 12.0–31.0
Gender: N (%)
Male 21 (43.8)
Female 27 (56.3)
Pre-operative behavior rating
Deﬁnitely negative (Frankl 1) 26 (54.2)
Negative (Frankl 2) 22 (45.8)
Table 2 Comparison of Trimeprazine sedation outcome
between age groups of children.
Sedation outcome Age groups (years)
3–5 6–8
N (%) N (%)
Successful 20 (76.9) 6 (23.1)
Partially successful 4 (40.0) 6 (60.0)
Unsuccessful 4 (33.3) 8 (66.7)
v2 = 8.165, df = 2, p= .017.
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and age group (X2 = 8.165, df = 2, p= .017), Table 2.
Majority (76.9%) of the successful sedation comprised chil-
dren in the 3–5 years age-group while most of the unsuccessful
cases (66.7%) were children in the 6–8 years age-group. Major-
ity (60.0%) of the children in the 6–8 years age-group were at
best partially successful (Table 2).
Sedation outcome also was associated with pre-operative
behavior rating. Children rated as deﬁnitely negative (Frankl
1) had 26.9% successful sedation whereas those rated as only
negative (Frankl 2) had 73.1% success. The difference was
quite signiﬁcant (X2 = 17.258, df = 2, p< .001), Table 3.
Analysis by gender of sedation outcome between males and fe-
males however, did not show any signiﬁcant difference,
p= .688 (Table 4).
For the successful and partially successful sessions, each
child had 1 or 2 quadrants of dental treatment completed when
possible. In some instances the amount of treatment was lim-
ited by the amount of local anesthetic that could be adminis-
tered. Procedures completed when sedation was at optimum
level included: Intracoronal restorations, pulp therapy, stain-
less steel crown and dental extractions.Table 3 Comparison of trimeprazine sedation outcome by
pre-operative behavior rating.
Sedation outcome Pre-operative behavior
Def. negative N (%) Negative N (%)
Successful 7 (26.9) 19 (73.1)
Partially successful 8 (80.0) 2 (20.0)
Unsuccessful 11 (91.7) 1 (8.3)
v2 = 17.258, df = 2, p< .001.4. Discussion
This study investigated the inﬂuence of factors such as age,
gender and pre-operative behavior rating on the outcome of
pediatric dental sedation using trimeprazine. Children of youn-
ger age-group were found to have more successful sedation
than the older age-group. That was not expected since both
the groups received similar dosage (3.8 mg/kg) of the medica-
tion calculated according to total body weight (Kizior and
Hodgson, 2000). This could be as a result of variability in
the patients’ responses to oral medications (Kizior and
Hodgson, 2000; Nathan and Vargas, 2002). It is also possible
that the sedative characteristics of the drug might be partly
responsible.
The three primary groups of drugs used for sedation in
Pediatric dentistry: the sedative-hypnotics, the anti-anxiety
agents and the narcotic analgesics, each act primarily in a dif-
ferent area of the brain to produce a distinct primary effect
(Wilson et al., 2005). While anti-anxiety agents act on Limbic
system to decrease anxiety and narcotics act on opioid recep-
tors of the CNS by raising the pain threshold, the effect of sed-
ative-hypnotic (e.g. trimeprazine) on the reticular activating
system (an area of the brain involved in maintaining con-
sciousness) is sedation or sleepiness (Wilson et al., 2005). The
ﬁnding in this study is consistent with the study report that
high dose of trimeprazine has been effective in young children
with sleep problems (Simonoff and Stores, 1987). Trimepra-
zine has no proven analgesic, amnestic and anxiolytic effect
(United States Pharmacopea, 1990). When used alone, a seda-
tive-hypnotic may lower the pain reaction threshold in some
cases and produce a patient who is more responsive to pain
stimulation (Wilson et al., 2005).
Two goals of pharmacological management of children are
to assist children in inducing their own coping skills and to
promote acceptance of the dental environment (Radis et al.,
1994). The selection of sedative agents, (e.g. anti-anxiety agent)
that increase the likelihood of rendering interactive behaviors
as opposed to noninteractive behavior (provided by sedative-
hypnotic agent) is reasonable for the older, more mature child.
There was no association between gender and sedation out-
come in this study. Both male and female subjects were simi-
larly affected among both successful and unsuccessful
sedation sessions. This is in agreement with earlier studies
(Van der Walt et al., 1987; Butt and Mets, 1988).
Another interesting ﬁnding in this study was the pre-opera-
tive behavior in relation to sedation outcome. A signiﬁcant
number of children rated as deﬁnitely negative (91.7%) had
unsuccessful sedation with trimeprazine. This conﬁrms Wilson
et al. (2000) the report that children who exhibit deﬁnitely
negative behavior tended to have poor abilities in coping with
90 L.L. Bellodental treatment. They were least cooperative; most often re-
fused to comply with requests and demonstrated the most dis-
ruptive behaviors. A dosage of any medication sufﬁcient to
sedate the truly resistive child may cause concomitant depres-
sion of cardio respiratory system or loss of protective reﬂexes
(Sullivan et al., 2001). Reductions in maximum dosages there-
fore, are advisable.
The limitations of this study are consistent with similar ret-
rospective studies. Several students were involved in the treat-
ment and evaluation of the children and were not trained
speciﬁcally for standardization of patient assessment as would
be in a prospective study. However, all students had a mini-
mum of one year of pediatric training and extensive experience
with behavior characteristics of difﬁcult to manage children.
Besides, the procedure was supervised by experienced faculty
member and data were collected according to AAPD guide-
lines for sedation.5. Conclusions
Based on this study’s results, the following conclusions can be
made:
1. Children 3–5 years old are more likely than children 6–
8 years to have successful sedation for dental procedures
using oral trimeprazine tartrate.
2. Children rated deﬁnitely negative (Frankl rating 1) are less
likely than those rated negative (Frankl rating 2), to have
successful sedation for dental procedures using trimepra-
zine tartrate.
3. There is no difference in pediatric sedation outcome for
dental procedures using oral trimeprazine between males
and females.References
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